Martin Samples
Head of Digital, Senior Vice President
Precision Value and Health
Innovating at the Intersection of Tech and Marketing
For 27+ years, Martin Samples has been a creator, a digital tinkerer, an innovator, and a problem-solver. In his twenties, Marty had a side-gig building custom PC clones with off-the shelf-hardware for General Electric engineers in his Cincinnati, OH neighborhood. Afterwards, he started his own computer hardware business setting up networks (wide area and local area) for companies. But eventually, he found his way to digital marketing.
In the 2000s, Marty joined Just Marketing International, which became the largest motorsports marketing company during his six years with the firm. He worked with teams to develop a software platform, “Creative Approval Pro,” which allowed clients—NASCAR, Formula 1, and the IndyCar Series—to take campaigns to market fast, letting their agencies pull creative assets, create materials, have them approved, and ready to go to market—within 10 days. Then he moved to Fusion Alliance, where he grew their digital practice from 25 to 100 people in less than five years and helped the company realize a 300% revenue growth.
Marty joined PRECISIONxtract in 2020 where his first assignment involved rebranding and creating new demand for Access Genius (a market access messaging app for HCPs to let them know the cost and coverage for a brand specific to the HCP’s patient population), and EHR Connect (solutions to help clients leverage EHR data and platforms to improve HCP and patient experience). His efforts led to additional brand awareness for two market-leading products by introducing novel digital lead generation and nurturing strategies and content maps.
In his latest role as Head of Digital for Precision Value and Health and co-leader of the Digital Center of Excellence (DCOE), Marty has introduced design thinking to PRECISIONxtract.
“We are creating tools that make it easier to implement solutions for us and our clients,” says Marty. “This approach will allow us to reduce the time to market for pharma clients, while giving them better data with which to measure the performance of what they do. And along with giving them tools to be more efficient, they will have tools that bring a new level of accountability and transparency to our work.”
